Redefining the Therapeutic Potential of Schedule 1 Drugs

At Innovation1 Biotech, we’re harnessing the raw power of botanical therapeutics, transforming them into fully synthetic drugs that provide a more consistent dose to enable safer and more reliable therapy.

About Us

Unique Pipeline Programs

We aim to capitalize on the growing global demand for pharmaceutical Schedule 1 drugs by developing and commercializing innovative analogs of natural botanical molecules.

Psilocin Analog for PTSD & Depression

Psilocin prodrug is a novel, sustained-release psychedelic molecule in development as a treatment for post-traumatic stress disorder (PTSD) and clinical depression.

Learn More
expand_more

18-MAC and THCV Prodrugs for Addiction

A combination therapy of two novel analogs of botanical molecules is in development for treatment of refractory drug addiction. 18-MethylAminoCoronaridine (18-MAC) is an analog of the botanical molecule ibogaine and tetrahydrocannabivarin (THCV) prodrug is a water-soluble cannabinoid receptor antagonist.

Learn More
expand_more

CBDP Prodrug for Refractory Pediatric Epilepsy

Cannabidiphorol (CBDP) prodrug is a novel, water-soluble analog of cannabidiol (CBD) in development for treatment of refractory pediatric epilepsy.

Learn More
expand_more

HU-308 Prodrug for Hypertrophic Scarring

HU-308 prodrug is a novel non-psychoactive cannabinoid analog of tetrahydrocannabinol (THC) that acts as a selective agonist of cannabinoid receptor 2 (CB2R) in development as a topical prophylactic measure to inhibit hypertrophic scarring after severe burn injury.

Learn More
expand_more

HU-308 Prodrug for Ocular Inflammation

HU-308 prodrug is a novel non-psychoactive cannabinoid analog of tetrahydrocannabinol (THC) that acts as a selective agonist of cannabinoid receptor 2 (CB2R) in development as a topical therapy of ocular inflammation.

Learn More
expand_more

MIOXAL®

A Nutraceutical Complex for Relief of Fibromyalgia and Chronic Fatigue Syndrome

Mioxal is a combination nutraceutical therapy comprising four GRAS (generally recognized as safe) ingredients that act together to support energy metabolism, improve mood, and reduce fatigue for individuals suffering from fibromyalgia and chronic fatigue syndrome.

About MIOXAL®

Latest News

View All News

Innovation1 Biotech (IVBT) Completes Name and Ticker Symbol Change from Gridiron BioNutrients (GMVP)

View All News

Investor Relations